NRAS and non-small cell lung carcinoma: Considering that NRAS mutations in NSCLC are more frequent in previous/current smokers (Ohashi et al., 2013), comprehensive genomic profiling of SCLC regardless of smoking status will be necessary to determine the true incidence of NRAS mutant SCLC.